USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ri.med Foundation

USPTO PatentsView assignee record - 9 granted patents across 12 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.2

Avg claims per patent

5-year filing velocity

The verdict

Ri.med holds 9 US patents across 12 technology areas, rank #29,931 of 50,000 tracked assignees.

#29,931
of 50,000 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 16.2
avg claims per patent

Portfolio overview

Ri.med Foundation has been granted 9 US utility patents between 2021 and 2025, placing Ri.med Foundation at rank #29,931 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a Foreign Corporation, Ri.med Foundation is one of the more focused assignees in the PatentsView dataset. By volume, Ri.med sits between Research Cancer Institute Of America (9 patents, rank #29,927) and Riva Health, Inc. (9 patents, rank #29,935) - the closest US assignees by grant volume. The composite Innovation Score of 41.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ri.med Foundation's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ri.med Foundation against peers pursuing similar technology classes.

Research Cancer I…

9
Retrace Labs

9
Retrocausal

9
Reverse Ionizer S…

9
Rideflux

9
Rimports

9
Rio Grande Neuros…

9
Riva Health

9
Ri MED Foundation ◀

9

What this shows Ri.med holds 9 patents at rank #29,931, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rimed

By rank, the assignees closest to #29,931 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Rimed's primary technology class.

Ri.med's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Ri.med Foundation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	3	33.3%
2022	1	11.1%
2023	1	11.1%
2024	3	33.3%
2025	1	11.1%

Which technologies does Ri.med Foundation patent most?

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 5

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 5

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

D01D - MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS 3

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3

C25D - PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR 2

D07B - ROPES OR CABLES IN GENERAL 1

D02G - CRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS 1

D10B - INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES 1

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Where it ranks

Overall rank by patents

#29,931

Across all tracked assignees

Innovation Score

41.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ri.med Foundation hold?

Ri.med Foundation holds 9 US granted patents filed between 2021 and 2025, spanning 12 technology areas.

What is Ri.med Foundation's Innovation Score?

Ri.med Foundation has an Innovation Score of 41.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ri.med Foundation focus on?

Ri.med Foundation's top technology area is A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES) with 5 patents. The company has filed patents in 12 CPC subclasses total.

Is Ri.med Foundation's patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Ri.med Foundation.

What does claim depth mean for Ri.med Foundation's patents?

Ri.med Foundation's patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Ri.med Foundation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Ri.med's 9 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Ri.med ranks #29,931 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61L - see who else leads that technology area. A61L leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.